DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kaletra (Lopinavir / Ritonavir) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (36)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 36   Next >>

Possible Kaletra side effects in male

Reported by a pharmacist from Canada on 2012-08-09

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2010-09-15

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in

Reported by a consumer/non-health professional from France on 2012-07-30

Patient:

Reactions: Drug Eruption, Death, Aspartate Aminotransferase Increased, Anaemia, Neutropenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-30

Rifampin
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-08-10

Isentress
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-30
    End date: 2010-08-31

Isoniazid
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-08-10

Dapsone
    Dosage: 100 mg, qd
    Indication: Prophylaxis
    Start date: 2011-01-15

Pyrazinamide
    Dosage: 2 g, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-07-26

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-30

Kaletra
    Dosage: 20
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-11-22

Other drugs received by patient: Bactrim; Leucovorin Calcium; Leucovorin Calcium; Ivermectin; Acyclovir; Ciproflaxacin; Azithromycin; Pyridoxine HCL; Omeprazole



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-06-29

Patient: female

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Zidovudine; Abacavir; Lamivudine



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-06-21

Patient: female

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine; Abacavir; Zidovudine



Possible Kaletra side effects in male

Reported by a physician from Guinea-Bissau on 2012-06-15

Patient: male

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Zidovudine; Lamivudine; Cotrim; Fluconazole; Abacavir; Leucovorin Calcium



Possible Kaletra side effects in male

Reported by a physician from Germany on 2012-06-05

Patient: male

Reactions: Death, Pancreatic Carcinoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Invirase; Aspirin; Fluconazole; Pantoprazole; Torsemide



Possible Kaletra side effects in male

Reported by a physician from South Africa on 2012-05-18

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Death, Renal Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine (Epivir Hbv); Zidovudine; Folic Acid; Cotrim



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Dosage: 200mg/50mg
    Administration route: Oral
    Indication: Antiretroviral Therapy

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-11

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra



Possible Kaletra side effects in male

Reported by a physician from Canada on 2012-05-10

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2007-07-11
    End date: 2010-07-04

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Canada on 2012-04-20

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra



Possible Kaletra side effects in male

Reported by a pharmacist from Canada on 2012-04-13

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50 mg
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2007-11-01

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Canada on 2012-04-12

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2007-07-11
    End date: 2010-07-04

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-06

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Dapsone



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-04-05

Patient: female

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Zidovudine; Cotrim; Lamivudine; Folic Acid



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-04-05

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine; Abacavir; Cotrim; Folic Acid



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-04-02

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Folic Acid; Lamivudine (Epivir Hbv); Abacavir; Cotrim



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-30

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra



Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-30

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Dosage: 200 /50mg
    Administration route: Oral
    Indication: HIV Infection

Kaletra
    Indication: Antiretroviral Therapy



Possible Kaletra side effects in 41 year old male

Reported by a physician from Japan on 2012-03-28

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Other drugs received by patient: Retrovir; Viracept; Recombinate; Loperamide HCL; Crixivan; Octocog Alpha; Loperamide HCL; OIF



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Canada on 2012-03-07

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Dosage: 200/50 mg
    Administration route: Oral
    Indication: Antiretroviral Therapy

Kaletra
    Indication: HIV Infection



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Canada on 2012-03-06

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-02-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Cotrim; Lamivudine; Zidovudine; Folic Acid



Possible Kaletra side effects in male

Reported by a physician from Guinea-Bissau on 2012-02-24

Patient: male, weighing 50.5 kg (111.1 pounds)

Reactions: Death, Pyrexia, Headache

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Folic Acid; Zidovudine; Cotrim; Lamivudine



Possible Kaletra side effects in male

Reported by a physician from Guinea-Bissau on 2012-02-24

Patient: male, weighing 45.0 kg (99.0 pounds)

Reactions: Death, Diarrhoea, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: AZT + 3TC; Lamivudine; Cotrim; Isoniazid; Zidovudine



Possible Kaletra side effects in 41 year old male

Reported by a physician from Japan on 2012-02-20

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin Rdna
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Other drugs received by patient: OIF; Loperamide HCL; Retrovir; Crixivan; Viracept; Recombinate; Loperamide HCL



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-02-16

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Cotrim; Folic Acid; Zidovudine; Lamivudine



Possible Kaletra side effects in male

Reported by a physician from Guinea-Bissau on 2012-02-15

Patient: male, weighing 50.5 kg (111.1 pounds)

Reactions: Death, Headache, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Cotrim; Folic Acid; Lamivudine(pepfar); Zidovudine



Possible Kaletra side effects in 45 year old male

Reported by a physician from Canada on 2012-02-10

Patient: 45 year old male

Reactions: Death, Muscular Weakness, Viith Nerve Paralysis, Meningitis Aseptic

Adverse event resulted in: death

Drug(s) suspected as cause:
Kaletra
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-01

Abacavir Sulfate / Lamivudine
    Dosage: 1.0 dosage forms, once
    Administration route: Oral
    Indication: HIV Test Positive
    Start date: 2010-01-01
    End date: 2010-01-01



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-01-27

Patient: female

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Zidovudine; Lamivudine; Codeira; Cotrim; Folic Acid; Alvitil Xarope; TOT Hema



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017